Disease Management

Resource Center

FDA Alerts

FDA Alert

FDA Approves First Pancreatic Islet Cell Therapy for Adults with Type 1 Diabetes

07/19/2023

Jessica Ganga

Following two studies, the FDA has approved the first cellular therapy for the treatment of type 1 diabetes in patients.

07/19/2023

Research Summaries

Research Summary

AGA Releases First Guidelines on Using Biomarkers for Monitoring Crohn Disease in Patients

02/27/2024

Jessica Ganga

Researchers with the American Gastroenterological Association (AGA) release a comprehensive set of guidelines on the use of biomarkers for monitoring and managing Crohn disease in patients.

02/27/2024

Conference Coverage

Ibrutinib Dose Adjustments Do Not Impact Time to Next Treatment For Patients With Chronic Lymphocytic Leukemia

01/31/2024

Anthony Calabro, MA

Researchers set out to compare the time until the next treatment in patients with chronic lymphocytic leukemia who are treated with single-agent ibrutinib at a sustained dose of 420 mg/day vs patients who...

01/31/2024

FDA Alert

FDA Approves First Pancreatic Islet Cell Therapy for Adults with Type 1 Diabetes

07/19/2023

Jessica Ganga

Following two studies, the FDA has approved the first cellular therapy for the treatment of type 1 diabetes in patients.

07/19/2023

Research Summary

New Guidelines for Treatment of CKD, Diabetes Emphasizes Comprehensive Care

02/03/2023

The Work Group from the Kidney Disease: Improving Global Outcomes organization updated its set of guidelines that offers clinical practice guidelines in the treatment of chronic kidney disease and...

02/03/2023

Management

Celiac Disease Diagnosis, Management Guidelines Updated

01/16/2023

The American College of Gastroenterology (ACG) provides new updates for clinicians and patients with recommendations for the diagnosis and management of celiac disease.

01/16/2023

April 2024

Current Issue

April 2024

Volume 64

Issue 4